4//SEC Filing
Ros Matthew 4
Accession 0000899243-22-000691
CIK 0001622229other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:24 PM ET
Size
5.9 KB
Accession
0000899243-22-000691
Insider Transaction Report
Form 4
Ros Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-01-03$5.15/sh+2,256$11,625→ 2,256 totalExercise: $8.70Exp: 2032-01-03→ Common Stock (2,256 underlying)
Footnotes (2)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
- [F2]This option is fully vested at time of grant.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001673802
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 9:24 PM ET
- Size
- 5.9 KB